Ovarian Cancer Data Analysis using Deep Learning: A Systematic Review from the Perspectives of Key Features of Data Analysis and AI Assurance

• URL: http://arxiv.org/abs/2311.11932v1
• Date: Mon, 20 Nov 2023 17:17:29 GMT
• Title: Ovarian Cancer Data Analysis using Deep Learning: A Systematic Review from the Perspectives of Key Features of Data Analysis and AI Assurance
• Authors: Muta Tah Hira, Mohammad A. Razzaque, and Mosharraf Sarker
• Abstract summary: Machine or Deep Learning (ML/DL)-based autonomous data analysis tools can assist clinicians and cancer researchers in discovering patterns and relationships from complex data sets. Many DL-based analyses on ovarian cancer (OC) data have recently been published. However, a comprehensive understanding of these analyses in terms of these features and AI assurance (AIA) is currently lacking.
• Score: 0.0
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Background and objectives: By extracting this information, Machine or Deep Learning (ML/DL)-based autonomous data analysis tools can assist clinicians and cancer researchers in discovering patterns and relationships from complex data sets. Many DL-based analyses on ovarian cancer (OC) data have recently been published. These analyses are highly diverse in various aspects of cancer (e.g., subdomain(s) and cancer type they address) and data analysis features. However, a comprehensive understanding of these analyses in terms of these features and AI assurance (AIA) is currently lacking. This systematic review aims to fill this gap by examining the existing literature and identifying important aspects of OC data analysis using DL, explicitly focusing on the key features and AI assurance perspectives. Methods: The PRISMA framework was used to conduct comprehensive searches in three journal databases. Only studies published between 2015 and 2023 in peer-reviewed journals were included in the analysis. Results: In the review, a total of 96 DL-driven analyses were examined. The findings reveal several important insights regarding DL-driven ovarian cancer data analysis: - Most studies 71% (68 out of 96) focused on detection and diagnosis, while no study addressed the prediction and prevention of OC. - The analyses were predominantly based on samples from a non-diverse population (75% (72/96 studies)), limited to a geographic location or country. - Only a small proportion of studies (only 33% (32/96)) performed integrated analyses, most of which used homogeneous data (clinical or omics). - Notably, a mere 8.3% (8/96) of the studies validated their models using external and diverse data sets, highlighting the need for enhanced model validation, and - The inclusion of AIA in cancer data analysis is in a very early stage; only 2.1% (2/96) explicitly addressed AIA through explainability.

Related papers

• SemioLLM: Assessing Large Language Models for Semiological Analysis in Epilepsy Research [45.2233252981348]
  Large Language Models have shown promising results in their ability to encode general medical knowledge. We test the ability of state-of-the-art LLMs to leverage their internal knowledge and reasoning for epilepsy diagnosis.
  arXiv  Detail & Related papers  (2024-07-03T11:02:12Z)
• Applications of artificial intelligence in the analysis of histopathology images of gliomas: a review [0.33999813472511115]
  This review examines 83 publicly available research studies that have proposed AI-based methods for whole-slide histopathology images of human gliomas. The focus of current research is the assessment of hematoxylin and eosin-stained tissue sections of adult-type diffuse gliomas. So far, AI-based methods have achieved promising results, but are not yet used in real clinical settings.
  arXiv  Detail & Related papers  (2024-01-26T17:29:01Z)
• De-identification of clinical free text using natural language processing: A systematic review of current approaches [48.343430343213896]
  Natural language processing has repeatedly demonstrated its feasibility in automating the de-identification process. Our study aims to provide systematic evidence on how the de-identification of clinical free text has evolved in the last thirteen years.
  arXiv  Detail & Related papers  (2023-11-28T13:20:41Z)
• Machine Learning Based Analytics for the Significance of Gait Analysis in Monitoring and Managing Lower Extremity Injuries [0.0]
  The research focused on the proficiency of supervised machine learning models predicting complications. XGBoost was the optimal model both before and after applying SMOTE. The findings support a shift in orthopedics towards a data-informed approach, enhancing patient outcomes.
  arXiv  Detail & Related papers  (2023-09-27T20:12:19Z)
• Assessing Utility of Differential Privacy for RCTs [44.15661493715815]
  We empirically assess the impact of strong privacy-preservation methodology (with acDP guarantees) on published analyses from RCTs. We find that relatively straightforward DP-based methods allow for inference-valid protection of the published data.
  arXiv  Detail & Related papers  (2023-09-26T00:10:32Z)
• Artificial intelligence in digital pathology: a diagnostic test accuracy systematic review and meta-analysis [0.3957768262206625]
  This systematic review and meta-analysis included diagnostic accuracy studies using any type of artificial intelligence applied to whole slide images (WSIs) in any disease type. 100 studies were identified for inclusion, equating to over 152,000 whole slide images (WSIs) and representing many disease types. These studies reported a mean sensitivity of 96.3% (CI 94.1-97.7) and mean specificity of 93.3% (CI 90.5-95.4) for AI. Overall, AI offers good accuracy when applied to WSIs but requires more rigorous evaluation of its performance.
  arXiv  Detail & Related papers  (2023-06-13T00:45:54Z)
• Artificial Intelligence in Ovarian Cancer Histopathology: A Systematic Review [1.832300121391956]
  Methods: A search of PubMed, Scopus, Web of Science, CENTRAL, and WHO-ICTRP was conducted. Risk of bias was assessed using PROBAST. There were 80 models of interest, including 37 diagnostic models, 22 prognostic models, and 21 models with other diagnostically relevant outcomes. All models were found to be at high or unclear risk of bias overall, with most research having a high risk of bias in the analysis.
  arXiv  Detail & Related papers  (2023-03-31T12:26:29Z)
• Trustworthy Visual Analytics in Clinical Gait Analysis: A Case Study for Patients with Cerebral Palsy [43.55994393060723]
  gaitXplorer is a visual analytics approach for the classification of CP-related gait patterns. It integrates Grad-CAM, a well-established explainable artificial intelligence algorithm, for explanations of machine learning classifications.
  arXiv  Detail & Related papers  (2022-08-10T09:21:28Z)
• Enabling scalable clinical interpretation of ML-based phenotypes using real world data [0.0]
  This study investigates approaches to perform patient stratification analysis at scale using large EHR datasets. We have developed several tools to facilitate the clinical evaluation and interpretation of unsupervised patient stratification results.
  arXiv  Detail & Related papers  (2022-08-02T17:31:03Z)
• Federated Learning Enables Big Data for Rare Cancer Boundary Detection [98.5549882883963]
  We present findings from the largest Federated ML study to-date, involving data from 71 healthcare institutions across 6 continents. We generate an automatic tumor boundary detector for the rare disease of glioblastoma. We demonstrate a 33% improvement over a publicly trained model to delineate the surgically targetable tumor, and 23% improvement over the tumor's entire extent.
  arXiv  Detail & Related papers  (2022-04-22T17:27:00Z)
• Machine Learning Methods for Histopathological Image Analysis: A Review [62.14548392474976]
  Histopathological images (HIs) are the gold standard for evaluating some types of tumors for cancer diagnosis. One of the ways of accelerating such an analysis is to use computer-aided diagnosis (CAD) systems.
  arXiv  Detail & Related papers  (2021-02-07T19:12:32Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.